The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 16, 2014

Filed:

Jun. 25, 2010
Applicants:

Ronald Schoenmakers, Rijswijk, NL;

Wilfried Weber, Freiburg, DE;

Marc Gitzinger, Binningen, CH;

Martin Fussenegger, Mägenwil, CH;

Marcel Tigges, Bettingen, CH;

Peter Schneider, Bottmingen, CH;

Inventors:

Ronald Schoenmakers, Rijswijk, NL;

Wilfried Weber, Freiburg, DE;

Marc Gitzinger, Binningen, CH;

Martin Fussenegger, Mägenwil, CH;

Marcel Tigges, Bettingen, CH;

Peter Schneider, Bottmingen, CH;

Assignee:

Bioversys AG, Basel, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4965 (2006.01); C07D 295/108 (2006.01); C07D 413/02 (2006.01); C07D 413/06 (2006.01); A61K 31/167 (2006.01); A61K 45/06 (2006.01); A61K 31/443 (2006.01); A61K 31/4015 (2006.01); A61K 31/17 (2006.01); C07D 265/30 (2006.01); A61K 31/4439 (2006.01); A61K 31/496 (2006.01); C07D 207/12 (2006.01); C07D 241/04 (2006.01); A61K 31/397 (2006.01); C07D 207/08 (2006.01); C07D 295/185 (2006.01); A61K 31/341 (2006.01); C07D 401/06 (2006.01); C07D 205/04 (2006.01); A61K 31/40 (2006.01); A61K 31/5377 (2006.01); C07D 213/74 (2006.01); A61K 31/44 (2006.01); C07D 213/38 (2006.01); C07D 413/04 (2006.01); A61K 31/7008 (2006.01); A61K 31/5375 (2006.01); C07D 307/32 (2006.01); A61K 31/495 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4015 (2013.01); C07D 413/02 (2013.01); C07D 413/06 (2013.01); A61K 31/167 (2013.01); A61K 45/06 (2013.01); A61K 31/443 (2013.01); A61K 31/17 (2013.01); C07D 265/30 (2013.01); A61K 31/4439 (2013.01); A61K 31/496 (2013.01); C07D 207/12 (2013.01); C07D 241/04 (2013.01); A61K 31/397 (2013.01); C07D 207/08 (2013.01); C07D 295/185 (2013.01); A61K 31/341 (2013.01); C07D 401/06 (2013.01); C07D 205/04 (2013.01); A61K 31/40 (2013.01); A61K 31/5377 (2013.01); C07D 213/74 (2013.01); A61K 31/44 (2013.01); C07D 213/38 (2013.01); C07D 413/04 (2013.01); A61K 31/7008 (2013.01); A61K 31/5375 (2013.01); C07D 307/32 (2013.01); A61K 31/495 (2013.01);
Abstract

The invention relates to a pharmaceutical composition comprising a compound of formula (1) wherein Ris optionally substituted phenyl, optionally substituted pyridyl or optionally substituted indolyl; Ris (CH)wherein n is 0, 1, 2, 3 or 4; Ris (CH)Rwherein m is 0, 1, 2, 3 or 4, and Ris methyl, isopropyl, tert-butyl, OCH, OH, optionally substituted phenoxy, C≡CH, C≡N, optionally substituted phenyl, furanyl or thienyl; A is a ring containing Xwith the meaning O, S, NH, N(CH) or CH; and Xis O, S or NH; and a compound of formula (2) wherein Ris optionally substituted phenyl, optionally substituted pyridyl, optionally substituted indolyl, —NRR; or —NH—N═CH—R; and substituents Rto Rhave the meanings indicated in the description, in particular ethionamide. The pharmaceutical composition is useful, e.g., in the treatment of multidrug-resistant tuberculosis.


Find Patent Forward Citations

Loading…